EFFECT OF GEMFIBROZIL ON THE CONCENTRATION AND COMPOSITION OF VERY-LOW-DENSITY AND LOW-DENSITY-LIPOPROTEIN SUBFRACTIONS IN HYPERTRIGLYCERIDEMIC PATIENTS
C. Dachet et al., EFFECT OF GEMFIBROZIL ON THE CONCENTRATION AND COMPOSITION OF VERY-LOW-DENSITY AND LOW-DENSITY-LIPOPROTEIN SUBFRACTIONS IN HYPERTRIGLYCERIDEMIC PATIENTS, Atherosclerosis, 113(1), 1995, pp. 1-9
The effect of gemfibrozil treatment on very low (VLDL) and low (LDL) d
ensity lipoprotein subfractions has been investigated in 9 moderate hy
pertriglyceridemic (HTG) patients (triglyceride (TG) levels 237-426 mg
/dl). Three VLDL subfractions, VLDL1 (Sf 175-400), VLDL2 (Sf 100-175)
and VLDL3 (Sf 20-100) and 4 LDL subspecies, LDL1 (1.023-1.028 g/ml), L
DL2(1.029-1.037 g/ml), LDL3(1.038-1.049 g/ml) and LDL4 (1.050-1.062 g/
ml) were prepared by density gradient ultracentrifugation. High densit
y lipoprotein (HDL) chemical composition and lipolytic activities afte
r heparin injection were also determined. Gemfibrozil induced a net de
crease in VLDL1 and VLDL2 concentrations (P < 0.01). Cholesteryl ester
(CE) weight percent was significantly reduced in both VLDL1 and VLDL2
subfractions. VLDL3 concentration and composition were not changed by
the treatment. Lipoprotein lipase (LPL) activity was reduced in HTG p
atients (P < 0.05). After treatment, LPL activity increased (P < 0.05)
but remained lower than in control, normotriglyceridemic (NTG) subjec
ts. Furthermore, gemfibrozil increased HDL cholesterol (P < 0.05) and
normalised the elevated HDL2 and HDL3 TG content. The increase of LDL
cholesterol, often observed after gemfibrozil treatment, was due to a
rise in the LDL2 subfraction (1.029 < d < 1.037 g/ml), the main fracti
on present in control subjects, However, despite the significant decre
ase of total plasma TG (329 mg/dl vs. 174 mg/dl), LDL3 subfraction (1.
038 < d < 1.049 g/ml) was not reduced.